Lafont C, Krams T (2022) Hip fracture and orthogeriatrics. Pathy’s Princ Prac Geriatri Med 2:992–1006
Chen J-L, Tai T-W, Chou C-Y, Ku C-K, Chien L-N, Huang T-W, Tang C-H (2022) Incidence of different types of subsequent fractures and related mortality in Taiwan. Arch Osteoporos 17:55
Schemitsch E, Adachi JD, Brown JP, Tarride J-E, Burke N, Oliveira T, Slatkovska L (2022) Hip fracture predicts subsequent hip fracture: a retrospective observational study to support a call to early hip fracture prevention efforts in post-fracture patients. Osteoporos Int 33:113–122
Reid IR, Billington EO (2022) Drug therapy for osteoporosis in older adults. Lancet 399:1080–1092
Article PubMed CAS Google Scholar
Davis S, Simpson E, Hamilton J, Martyn-St James M, Rawdin A, Wong R, Goka E, Gittoes N, Selby P (2020) Denosumab, raloxifene, romosozumab and teriparatide to prevent osteoporotic fragility fractures: a systematic review and economic evaluation. Health Technology assessment (Winchester, England) 24:1
Patsiogiannis N, Kanakaris NK, Giannoudis PV (2021) Periprosthetic hip fractures: an update into their management and clinical outcomes. EFORT Open Reviews 6:75–92
Article PubMed PubMed Central Google Scholar
Jennison T, Yarlagadda R (2018) Mortality in patients sustaining a periprosthetic fracture following a hemiarthroplasty. J Orthop 15:798–801. https://doi.org/10.1016/j.jor.2018.05.031
Article PubMed PubMed Central Google Scholar
McGraw IW, Spence SC, Baird EJ, Eckhardt SM, Ayana GE (2013) Incidence of periprosthetic fractures after hip hemiarthroplasty: are uncemented prostheses unsafe? Injury 44:1945–1948. https://doi.org/10.1016/j.injury.2013.07.023
Griffiths EJ, Cash DJ, Kalra S, Hopgood PJ (2013) Time to surgery and 30-day morbidity and mortality of periprosthetic hip fractures. Injury 44:1949–1952. https://doi.org/10.1016/j.injury.2013.03.008
Article PubMed CAS Google Scholar
Wang C-Y, Fu S-H, Yang R-S, Chen L-K, Shen L-J, Hsiao F-Y (2020) Timing of anti-osteoporosis medications initiation after a hip fracture affects the risk of subsequent fracture: a nationwide cohort study. Bone 138:115452
Hsieh CY, Su CC, Shao SC, Sung SF, Lin SJ, Kao Yang YH, Lai EC (2019) Taiwan’s National Health Insurance Research Database: past and future. Clin Epidemiol 11:349–358. https://doi.org/10.2147/clep.S196293
Article PubMed PubMed Central Google Scholar
Desai RJ, Mahesri M, Abdia Y, Barberio J, Tong A, Zhang D, Mavros P, Kim SC, Franklin JM (2018) Association of osteoporosis medication use after hip fracture with prevention of subsequent nonvertebral fractures: an instrumental variable analysis - PubMed. JAMA Netw Open 1.https://doi.org/10.1001/jamanetworkopen.2018.0826
Fu SH, Wang CY, Hung CC, Lee CC, Yang RS, Huang CC, Farn CJ, Lin WH, Chen HM, Hsiao FY, Lin JW, Li CY (2021) Increased fracture risk after discontinuation of anti-osteoporosis medications among hip fracture patients: a population-based cohort study. J Intern Med 290:1194–1205. https://doi.org/10.1111/joim.13354
Article PubMed CAS Google Scholar
Lee MT, Fu SH, Hsu CC, Chen HM, Lin JW, Tsai KS, Hwang JS, Lin SC, Wu CH, Wang CY (2023) Epidemiology and clinical impact of osteoporosis in Taiwan: a 12-year trend of a nationwide population-based study. J Formos Med Assoc 122(Suppl 1):S21-s35. https://doi.org/10.1016/j.jfma.2023.05.001
Ratnasamy PP, Rudisill KE, Oghenesume OP, Riedel MD, Grauer JN (2023) Risk of contralateral hip fracture following initial hip fracture among geriatric fragility fracture patients. JAAOS Global Research & Reviews 7:e23
Fu S-H, Yu P-Y, Li C-Y, Hung C-C, Lee C-C, Chen H-Y, Tai T-W, Hwang J-S, Yang R-S, Chiang H, Lin S-Y, Wu C-H, Liao L-C, Chuang C-J, Wu C-Y, Chang C-Y, Lee M-T, Chen C-H, Wang C-Y (2023) Diagnostic accuracy of algorithms to define incident and second hip fractures: a Taiwan validation study. J Formos Med Assoc 122:S82–S91. https://doi.org/10.1016/j.jfma.2023.05.037
Mazzucchelli R, Pérez-Fernández E, Crespí N, García-Vadillo A, Rodriguez Caravaca G, Gil de Miguel A, Carmona L (2018) Second hip fracture: incidence, trends, and predictors. Calcified Tissue International. 102:619–626. https://doi.org/10.1007/s00223-017-0364-2
Article PubMed CAS Google Scholar
Yu S-F, Cheng J-S, Chen Y-C, Chen J-F, Hsu C-Y, Lai H-M, Ko C-H, Chiu W-C, Su Y-J, Cheng T-T (2019) Adherence to anti-osteoporosis medication associated with lower mortality following hip fracture in older adults: a nationwide propensity score-matched cohort study. BMC Geriatr 19:290. https://doi.org/10.1186/s12877-019-1278-9
Article PubMed PubMed Central Google Scholar
Baggott PJ, Farook MZ, Pritchard M, Singh H, Bista A, Sobti A, Unnithan A, Baggott J (2022) Periprosthetic femoral fractures and their surgical outcomes between 2011 and 2021: a single-centre observational study. Cureus 14(8). https://doi.org/10.7759/cureus.28341
Fenelon C, Murphy EP, Kearns SR, Curtin W, Murphy CG (2020) A growing challenge: the rise of femoral periprosthetic fractures - an 11-year observational study. Surgeon 18:19–23. https://doi.org/10.1016/j.surge.2019.05.001
Article PubMed CAS Google Scholar
Günther K-P, Deckert S, Lützner C, Lange T, Schmitt J, Postler A (2021) Total hip replacement for osteoarthritis—evidence-based and patient-oriented indications. Dtsch Arztebl Int 118:730
PubMed PubMed Central Google Scholar
Söreskog E, Ström O, Spångéus A, Åkesson KE, Borgström F, Banefelt J, Toth E, Libanati C, Charokopou M (2020) Risk of major osteoporotic fracture after first, second and third fracture in Swedish women aged 50 years and older. Bone 134:115286
Tai TW, Huang CF, Huang HK, Yang RS, Chen JF, Cheng TT, Chen FP, Chen CH, Chang YF, Hung WC, Han DS, Chan DC, Tsai CC, Chen IW, Chan WP, Chang HJ, Hwang JS, Wu CH (2023) Clinical practice guidelines for the prevention and treatment of osteoporosis in Taiwan: 2022 update. J Formos Med Assoc 122(Suppl 1):S4–S13. https://doi.org/10.1016/j.jfma.2023.01.007
Miettinen S, Sund R, Törmä S, Kröger H (2023) How often do complications and mortality occur after operatively treated periprosthetic proximal and distal femoral fractures? A register-based study - PubMed. Clin Orthop Relat Res 481. https://doi.org/10.1097/CORR.0000000000002638.
GJ DR (2013) Periprosthetic fractures about the knee - an overview. J Knee Surg 26. https://doi.org/10.1055/s-0033-1333900
Epidemiology and characteristics of femoral periprosthetic fractures : data from the characteristics, outcomes and management of periprosthetic fracture service evaluation (COMPOSE) cohort study - PubMed. The bone and joint journal. 2022 Aug; 104-B. https://doi.org/10.1302/0301-620X.104B8.BJJ-2021-1681.R1
Gj DR, Ks L, Hc P (2011) Periprosthetic fractures: epidemiology and future projections - PubMed. J Orthop Trauma 25(Suppl):2. https://doi.org/10.1097/BOT.0b013e31821b8c28
Carballido-Gamio J, Marques EA, Sigurdsson S, Siggeirsdottir K, Jensen A, Sigurdsson G, Aspelund T, Gudnason V, Lang TF, Harris TB (2024) Male-female spatio-temporal differences of age-related bone changes show faster bone deterioration in older women at femoral regions associated with incident hip fracture . J Bone Miner Res: Off J Am Soc Bone Miner Res 39. https://doi.org/10.1093/jbmr/zjae132
Helynen N, Rantanen L, Lehenkari P, Valkealahti M (2023) Predisposing factors for a second fragile hip fracture in a population of 1130 patients with hip fractures, treated at Oulu University Hospital in 2013–2016: a retrospective study. Arch Orthop Trauma Surg 143:2261-2271. https://doi.org/10.1007/s00402-022-04406-4
Tm M, Dt M, Jh D, Sw G, Ct T (2020) Anatomic and patient risk factors for postoperative periprosthetic hip fractures: a case-control study - PubMed. The Journal of arthroplasty. https://doi.org/10.1016/j.arth.2020.02.007
Orwig DL, Abraham DS, Hochberg MC, Gruber-Baldini A, Guralnik JM, Cappola AR, Golden J, Hicks GE, Miller RR, Resnick B, Shardell M, Sterling RS, Bajracharya R, Magaziner J (2022) Sex differences in recovery across multiple domains among older adults with hip fracture. J Gerontol A Biol Sci Med Sci 77. https://doi.org/10.1093/gerona/glab271
Huang T-W, Wang C-J, Shih H-N, Chang Y, Huang K-C, Peng K-T, Lee MS (2017) Bone turnover and periprosthetic bone loss after cementless total hip arthroplasty can be restored by zoledronic acid: a prospective, randomized, open-label, controlled trial. BMC Musculoskelet Disord 18:1–10
Papaioannou A, Kennedy CC, Dolovich L, Lau E, Adachi JD (2007) Patient adherence to osteoporosis medications: problems, consequences and management strategies. Drugs Aging 24:37–55
Article PubMed CAS Google Scholar
Cohen J (2013) Statistical power analysis for the behavioral sciences. Routledge
Ayers C, Kansagara D, Lazur B, Fu R, Kwon A, Harrod C (2023) Effectiveness and Safety of treatments to prevent fractures in people with low bone mass or primary osteoporosis: a living systematic review and network meta-analysis for the American College of Physicians. Ann Intern Med 176. https://doi.org/10.7326/M22-0684
Sh F, Hk Y, Rs Y, Cc H, Jw L, Mt L, Hm C, Ch W, Cc H, Cy L, Oq G, Cy W (2025) Long dosing intervals of parenteral antiosteoporosis medications and the decrease in societal fracture risk: an 11-year nationwide population-based cohort study - PubMed. Mayo Clinic proceedings. https://doi.org/10.1016/j.mayocp.2024.05.002
Comments (0)